-
WES analysis in identifying additive genetic factors that may contribute to the occurrence of moyamoya in neurofibromatosis type 1
Study
EGAS00001003053
-
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma
Study
EGAS00001005478
-
TRACERx 100: metastatic samples
Study
EGAS00001002415
-
DERMATLAS__Porocarcinoma_WES
Study
EGAS00001005720
-
DERMATLAS__Porocarcinoma_RNAseq
Study
EGAS00001005721
-
Genetic variability in exon 1 of the glucocorticoid receptor gene NR3C1 is associated with postoperative complications
Study
EGAS00001005737
-
Human induced pluripotent stem cells display a similar mutation burden as embryonic pluripotent cells in vivo
Study
EGAS00001005939
-
Molecular programs of melanoma brain metastases (MBM)
Study
EGAS00001005976
-
Identification of gene mutations and fusion genes in patients with Sézary Syndrome
Study
EGAS00001001706
-
Whole exome sequencing data for patients with Bosma arhinia microphthalmia syndrome (BAMS).
Study
EGAS00001002193